Chemclin (China Diagnostic Medical Corporation)

Chemclin Biotech is a Chinese provider that is focused on in-vitro diagnostic instruments and auxiliary reagents for clinical diagnosis.

Launch date

1999

Employees

Market cap

Enterprise valuation

Beijing China (HQ)

Date	Investors	Amount	Round
May 2007	WI Harper Group SB China Capital Next47	$5.0m	Series A
Oct 2008	WI Harper Group SAIF Partners	$16.5m	Series B
Jan 2013	Actis	N/A	Acquisition
Aug 2018	China Renaissance Legend Capital Matrix Partners China Ping An Ventures FTZ Fund Management Highlight Capital	$293m	Growth Equity VC
Total Funding		AUD486m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Chemclin (China Diagnostic Medical Corporation)